MPWT
TRVI icon

MassMutual Private Wealth & Trust’s Trevi Therapeutics TRVI Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.62K Hold
516
– – ﹤0.01% 1423
2026
Q1 		$6.16K Hold
516
– – ﹤0.01% 1583
2025
Q4 		$6.46K Hold
516
– – ﹤0.01% 1571
2025
Q3 		$4.72K Sell
516
-12
-2% -$90 ﹤0.01% 1695
2025
Q2 		$2.89K Buy
+528
New +$3.29K ﹤0.01% 1839

Other funds holding TRVI

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
PP
PFS Partners Mine Hill, New Jersey $247M AUM 29.02% 1-Year Est. Return

MassMutual Private Wealth & Trust's TRVI Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Trevi Therapeutics (TRVI) position steady in Q2 2026 at 516 shares worth $9.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

MassMutual Private Wealth & Trust first reported a position in TRVI in Q2 2025 and has held it in 5 quarters since. 40 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • MassMutual Private Wealth & Trust held 516 shares of Trevi Therapeutics worth $9.62K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Trevi Therapeutics share count unchanged in Q2 2026.
  • Trevi Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1423 holding.
  • MassMutual Private Wealth & Trust first reported a position in Trevi Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 40 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.